September 19, 2011
Eisai announced on September 1 that its treatment for epilepsy Zonegran (zonisamide) was shown to be effective in previously treated children with epilepsy showing partial-onset seizures with a higher responder rate compared to placebo in an overseas PIII trial (Study...read more